Effect of Per-Rectal administration of Durvadi ghrita in Ulcerative colitis

Effect of Per-Rectal administration of Durvadi ghrita in Ulcerative colitis - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081486

Enrollment

Registered

2025-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K519- Ulcerative colitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Mild and moderate cases of Ulcerative colitis diagnosed and confirmed by colonoscopy 2.Participants with written informed consent

Exclusion criteria

Exclusion criteria: 1.Ulcerative colitis with complication of Intestinal obstruction, Fistula in ano, Toxic megalocolon,abscess and Pancolitis 2.Cases of Tuberculosis, Uncontrolled Diabets Mellitus,HIV, Carcinoma

Design outcomes

Primary

Measure	Time frame
Ulcerative Colitis Endoscopic Index of SeverityTimepoint: before and after treatment	—

Secondary

Measure	Time frame
Simple clinical colitis index BMI Hb, ESR, CRP Stool occult blood testTimepoint: Simple clinical colitis index assessed on 0th, 7th, 14th, 21st & 31st day BMI Hb ESR CRP Stool test assessed on 0th & 31st day	—

Countries

India

Contacts

Public ContactDr Deepa Jose

Government Ayurveda College, Tripunithura

jodrdeepa@gmail.com9446864399

Outcome results